<DOC>
	<DOCNO>NCT01592201</DOCNO>
	<brief_summary>The purpose study compare patient satisfaction continue administration previous antipsychotic versus switched administration paliperidone ER non-satisfied patient previous ( paliperidone )</brief_summary>
	<brief_title>A Comparative Study Patient Satisfaction Between Continued Administration Previous Antipsychotics Versus Switched Administration Paliperidone ER Non-satisfied Patients With Previous Antipsychotic Drug</brief_title>
	<detailed_description>This randomize ( patient assign intervention chance ) , prospective , open-label ( people involve know identity assign drug ) , switch study design evaluate patient-assessed medication satisfaction 12 week treatment patient schizophrenia . The total duration study 12 week . Outpatients treat atypical antipsychotic report dissatisfaction ( Medication Satisfaction Questionnaire [ MSQ ] &lt; 4 ) current treatment response eligible participate study . Patients randomize two group , 1 ) Patients randomize immediate initiation paliperidone ER total 12 week 2 ) Patients randomize delayed initiation continue previous atypical antipsychotic 8 week initiate paliperidone ER Day 56 4 week . During study treatment optimization do dose adjustment ( dose increase decrease ) add psychotropic agent except antipsychotic .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Must diagnose schizophrenia accord Diagnostic Statistical Manual Mental Disorders ( DSMIV ) criterion Have take atypical antipsychotic ( aripiprazole , olanzapine , risperidone ) least 6 week prior start study . Have Medication Satisfaction Questionnaire ( MSQ ) score ≤3 Competent patient manage answer questionnaire Have history current symptom tardive dyskinesia neuroleptic malignant syndrome Have relevant history current presence significant unstable cardiovascular , respiratory , neurological ( include seizure significant cerebrovascular ) , renal , hepatic , hematologic , endocrine , immunologic , morbid obesity ( BMI≥40 ) , systemic disease Had receive two different kind antipsychotic . Had history take paliperidone extend release ( ER ) . Allergy hypersensitivity risperidone paliperidone ER . Have clozapine longacting injectable antipsychotic medication last 3 month . Have Medication Satisfaction Questionnaire ( MSQ ) score &gt; 3 Have hospitalize longer 8 continuous week past 6 month Had history severe preexist gastrointestinal narrowing ( pathologic iatrogenic ) inability swallow oral tolerability medication whole aid water patient require oral tolerability test Current substance dependence ( DSMIV ) past history dependence ( 6 month )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Paliperidone ER</keyword>
	<keyword>Antipsychotics</keyword>
	<keyword>Mental disorder</keyword>
	<keyword>Comparative study</keyword>
</DOC>